CONSULTATION PROCESS ON NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDs) BEGINS
On the occasion of its Executive Board (EB) meeting held at the FEI Headquarters today, 9 March, the FEI announced further steps in relation to the debate on in-competition use of a limited number of non-steroidal anti-inflammatory drugs (NSAIDs) under strictly prescribed limits and set the relevant timeline.
A central point in the debate will [...]
